A strong cough and cold season helped Germany's OTC market through pharmacy achieve double-digit growth in 2022, according to data from IQVIA. Looking ahead, Sempora Consulting sees this positive momentum continuing, with consumers motivated to prevent illness through self-care. However, inflation and generic competition are putting pressure on brand owners to show value for their more expensive products, especially in non-critical health categories. Sempora offers its advice to German companies for 2023.
Germany’s self-medication market grew by 12% by sales volume to 980m packs in 2022, according to the latest data from IQVIA Commercial GmbH.
By sales value, the market through community and mail order pharmacy advanced by 7% to €6.3bn ($6.7bn) in the 12...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
